NEC aims to develop cancer drugs using artificial intelligence

NEC Corp. said it will develop cancer drugs using artificial intelligence, aiming to put new vaccines using peptides into practical use within the next eight years as key substances in next generation immunotherapy.
http://www.japantimes.co.jp/news/2016/12/19/business/tech/nec-aims-develop-cancer-drugs-using-artificial-intelligence/#.WFkWr1MrLIU